MedPath

Medfavour (Beijing) Medical Co., Ltd.

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:0

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (100.0%)

Safety and Efficacy Study of NOYA Sirolimus-Eluting Stent to Treat Coronary Artery Disease

Not Applicable
Conditions
Coronary Artery Disease
First Posted Date
2014-08-13
Last Posted Date
2014-08-13
Lead Sponsor
Medfavour (Beijing) Medical Co., Ltd
Target Recruit Count
2000
Registration Number
NCT02216058
Locations
🇨🇳

Chinese PLA General Hospital, Beijing, Beijing, China

NOYA CoCr Biodegradable Coating Sirolimus-Eluting Coronary Stent System

Not Applicable
Conditions
Coronary Artery Diseases
First Posted Date
2010-10-22
Last Posted Date
2012-05-22
Lead Sponsor
Medfavour (Beijing) Medical Co., Ltd
Target Recruit Count
300
Registration Number
NCT01226355
Locations
🇨🇳

Fuwai Hospital, National Center for Cardiovascular Diseases, Beijing, China

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.